Efficacy of Pyrazolopyrimidine Ribonucleosides Against Irypanosoma cruzi: Studies in Vitro and in Vivo with Sensitive and Resistant Strains

Authors:
  • RBR. L. Berens
    R. L. Berens
  • JMJ. J. Marr
    J. J. Marr
  • DLD. L. Looker
    D. L. Looker
  • DND. J. Nelson
    D. J. Nelson
  • SLS. W. LaFon
    S. W. LaFon

Abstract
Strains of Trypanosoma cruzi differ in their susceptibilities to and metabolism of pyrazolopyrimidines. Allopurinol riboside can control but not eliminate infections with a sensitive strain in both tissue culture and mice. Formycin B, which proved to be >10-fold more effective on a weight basis, showed a similar strain specificity but could eliminate an infection with a sensitive strain from tissue culture. However, this drug, unlike allopurinol riboside, was converted to toxic analogues of adenosine mono-, di-, and triphosphate by uninfected tissue culture cells. Thiopurinol and its riboside were effective against all strains unless culture was performed in purine-defined medium. Thus formycin B and allopurinol riboside appear to be good models for the design of anti-trypanosomal agents. Suitable modification of the molecule may provide an effective chemotherapeutic agent.

This publication has 14 references indexed in Scilit: